李衎 - Clinical Research, Merck & Co., Inc

基本信息

浏览量：2

职业迁徙

个人简介

暂无内容

研究兴趣

论文共 76 篇作者统计合作学者相似作者

按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选

Pembrolizumab for Locally Advanced Cervical Cancer

Domenica Lorusso,Karin Yamada,Kan Li,Annamaria Cerrotta,Gabriella Macchia

Lancet (London, England)no. 10467 (2024): 2050-2051

引用0浏览0WOS引用

Pembrolizumab Plus Chemotherapy for Advanced and Recurrent Cervical Cancer: Final Analysis According to Bevacizumab Use in the Randomized KEYNOTE-826 Study

D. Lorusso,N. Colombo,C. Dubot,M.V. Cáceres,K. Hasegawa,R. Shapira-Frommer,P. Salman,E. Yañez,M. Gümüş, M. Olivera,V. Samouëlian,V. Castonguay,A. Arkhipov,K. Li, S. Toker, C. Tekin,K.S. Tewari,B.J. Monk

Annals of Oncology（2024）

引用0浏览0WOS引用

Pembrolizumab or Placebo Plus Chemotherapy with or Without Bevacizumab for Persistent, Recurrent, or Metastatic Cervical Cancer Subgroup Analyses from the KEYNOTE-826 Randomized Clinical Trial

Krishnansu S. Tewari, Nicoletta Colombo, Bradley J. Monk,Coraline Dubot, M. Valeria Caceres,Kosei Hasegawa,Ronnie Shapira-Frommer,Pamela Salman,Eduardo Yanez,Mahmut Gumus, Mivael Olivera Hurtado de Mendoza,Vanessa Samouelian, Vincent Castonguay,Alexander Arkhipov,Cumhur Tekin,Kan Li, Sarper Toker,Stephen M. Keefe,Domenica Lorusso

JAMA ONCOLOGYno. 2 (2024): 185-192

引用0浏览0引用

A Phase 3 Study of Pembrolizumab Plus Chemoradiotherapy for High-Risk Locally Advanced Cervical Cancer

RADIOTHERAPY AND ONCOLOGY (2024): S1124-S1126

引用0浏览0引用

Impact of HER2-low Status for Patients with Early-Stage Breast Cancer and Non-Pcr after Neoadjuvant Chemotherapy: A National Cancer Database Analysis

Huiyue Li,Jennifer K. Plichta,Kan Li,Yizi Jin,Samantha M. Thomas,Fei Ma,Li Tang,Qingyi Wei,You-Wen He,Qichen Chen,Yuanyuan Guo,Yueping Liu,Jian Zhang,Sheng Luo

BREAST CANCER RESEARCH AND TREATMENTno. 1 (2024): 89-105

引用1浏览0WOS引用

Yelena Y. Janjigian,Akihito Kawazoe,Jianming Xu,Sara Lonardi,Jean-Philippe Metges,Lucjan S. Wyrwicz,Lin Shen,Yuriy Ostapenko,Mehmet Bilici,Maeve Aine Lowery,Adriana Valderrama, Yanfen Guan,Kan Li,Chie-Schin Shih,Sun Young Rha

Journal of Clinical Oncologyno. 3_suppl (2024): 286-286

引用0浏览0引用

Pembrolizumab Plus Chemoradiotherapy for High-Risk Locally Advanced Cervical Cancer: A Randomized, Doubleblind, Phase III ENGOT-cx11/GOG-3047/KEYNOTE-A18 Study

Linda Duska,Yang Xiang,Kosei Hasegawa,Giovanni Scambia, Manuel Leiva, Pier Anyelo Elias, Alejandro Acevedo,Julia Vizkeleti,Andrea Juliana Gomes, Fernando Contreras Mejia, Ari Reiss,Ali Ayhan,Jung-Yun Lee, Valeriya Saevets,Flora Zagouri,Kan Li, Karin Yamada, Sarper Toker,Sandro Pignata,Domenica Lorusso

GYNECOLOGIC ONCOLOGY (2024): S8-S9

引用1浏览0引用

Pembrolizumab Plus Chemotherapy With/without Bevacizumab in East Asian Patients with Persistent, Recurrent, or Metastatic Cervical Cancer: Results from KEYNOTE-826 Final Analysis

Yong Man Kim,Se Ik Kim,Shin Nishio,Kosei Hasegawa,Coraline Dubot,M. Valeria Cáceres,Krishnansu S. Tewari,Domenica Lorusso,Jeong-Won Lee, Wen-Shiung Liou,Kan Li,Cumhur Tekin,Bradley J. Monk,Nicoletta Colombo

Proceedings of the Biennial Meeting of Asian Society of Gynecologic Oncology (2024)

引用0浏览0引用

加载更多

作者统计

合作学者

合作机构

D-Core

合作者
学生
导师

暂无相似学者，你可以通过学者研究领域进行搜索筛选

数据免责声明

页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果，我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问，可以通过电子邮件方式联系我们：report@aminer.cn

Kan Li(李衎)

论文共 76 篇作者统计合作学者相似作者